Bausch + Lomb Corporation (BLCO) Stock Forecast & Price Target

Compare

139 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BLCO Analyst Ratings

Hold

3 Buy

8 Hold

1 Sell

Based on 12 analysts giving stock ratings to

Bausch

+ Lomb Corporation

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BLCO Stock 12 Month Forecast

Average Price Target

$15.82

▲(1.87% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Bausch + Lomb Corporation in the last 3 months. The average price target is $15.82 with a high forecast of $18.00 and a low forecast of $13.00. The average price target represents a 1.87% change from the last price of $15.53.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","21":"$21","12.75":"$12.75","15.5":"$15.5","18.25":"$18.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$18.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.82,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$13.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,12.75,15.5,18.25,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.94,15.175384615384615,15.41076923076923,15.646153846153846,15.881538461538462,16.116923076923076,16.352307692307694,16.587692307692308,16.823076923076922,17.05846153846154,17.293846153846154,17.529230769230768,17.764615384615386,{"y":18,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.94,15.007692307692308,15.075384615384616,15.143076923076922,15.21076923076923,15.278461538461539,15.346153846153847,15.413846153846153,15.481538461538461,15.54923076923077,15.616923076923078,15.684615384615384,15.752307692307692,{"y":15.82,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.94,14.79076923076923,14.641538461538461,14.492307692307692,14.343076923076923,14.193846153846154,14.044615384615383,13.895384615384614,13.746153846153845,13.596923076923076,13.447692307692307,13.298461538461538,13.149230769230769,{"y":13,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":20.51,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.47,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.06,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.35,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.1,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.59,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.45,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.45,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.5,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.81,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.67,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.94,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$18.00

Average Price Target$15.82

Lowest Price Target$13.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Saxon

Needham

―

Hold

―

Reiterated

11/05/25

Cautious Hold Rating for Bausch + Lomb Amid Market Position and Future Prospects

Matt Miksic

Barclays

$16→$17

Hold

9.47%

Upside

Reiterated

10/31/25

Bausch + Lomb Corporation (BLCO) Gets a Hold from Barclays

Patrick Wood

Morgan Stanley

$13→$14

Hold

-9.85%

Downside

Reiterated

10/31/25

Bausch + Lomb Corporation (BLCO) Gets a Hold from Morgan StanleyBausch + Lomb Corp Equal-Weight with price target revised from 13.00 to 14.00.

Yi Chen

H.C. Wainwright

$16→$17

Buy

9.47%

Upside

Reiterated

10/31/25

Bausch + Lomb price target raised to $17 from $16 at H.C. WainwrightBausch + Lomb price target raised to $17 from $16 at H.C. Wainwright

Robbie Marcus

J.P. Morgan

$13→$16

Hold

3.03%

Upside

Reiterated

10/30/25

Bausch + Lomb price target raised to $16 from $13 at JPMorganBausch + Lomb price target raised to $16 from $13 at JPMorgan

Larry Biegelsen

Wells Fargo

$15→$16

Hold

3.03%

Upside

Reiterated

10/30/25

Wells Fargo Sticks to Their Hold Rating for Bausch + Lomb Corporation (BLCO)

Douglas Miehm

RBC Capital

$17

Buy

9.47%

Upside

Reiterated

10/30/25

Analysts Offer Insights on Healthcare Companies: Align Tech (NASDAQ: ALGN), Bausch + Lomb Corporation (NYSE: BLCO) and LivaNova (NASDAQ: LIVN)

Jack Scalprey

TR | OpenAI - 4o

$15→$16

Hold

3.03%

Upside

Reiterated

10/30/25

AI Generated ArticleAI Generated Article

Unknown Analyst

Evercore ISI

Not Ranked

Evercore ISI

$17→$18

Buy

15.90%

Upside

Reiterated

10/30/25

Evercore ISI Reaffirms Their Buy Rating on Bausch + Lomb Corporation (BLCO)

Travis Steed

Bank of America Securities

$13

Sell

-16.29%

Downside

Reiterated

10/29/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (NYSE: BLCO), United Therapeutics (NASDAQ: UTHR) and Unicycive Therapeutics (NASDAQ: UNCY)

Thomas Stephan

Stifel Nicolaus

$14

Hold

-9.85%

Downside

Reiterated

10/29/25

Cautious Outlook for Bausch + Lomb: Hold Rating Amid Mixed Performance and Challenging Guidance

Unknown Analyst

Evercore ISI

Not Ranked

Evercore ISI

$16.5→$17

Buy

9.47%

Upside

Reiterated

10/07/25

Bausch + Lomb Corporation (BLCO) Gets a Buy from Evercore ISI

Joanne Wuensch

Citi

$15→$16

Hold

3.03%

Upside

Reiterated

10/07/25

Bausch + Lomb price target raised to C$16 from C$15 at CitiBausch + Lomb price target raised to C$16 from C$15 at Citi

David Roman

Goldman Sachs

$16

Hold

3.03%

Upside

Initiated

10/01/25

Bausch + Lomb initiated with a Neutral at Goldman SachsBausch + Lomb initiated with a Neutral at Goldman Sachs

Unknown Analyst

Evercore ISI

Not Ranked

Evercore ISI

$16→$16.5

Buy

6.25%

Upside

Reiterated

07/31/25

Evercore ISI Sticks to Their Buy Rating for Bausch + Lomb Corporation (BLCO)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Saxon

Needham

―

Hold

―

Reiterated

11/05/25

Cautious Hold Rating for Bausch + Lomb Amid Market Position and Future Prospects

Matt Miksic

Barclays

$16→$17

Hold

9.47%

Upside

Reiterated

10/31/25

Bausch + Lomb Corporation (BLCO) Gets a Hold from Barclays

Patrick Wood

Morgan Stanley

$13→$14

Hold

-9.85%

Downside

Reiterated

10/31/25

Bausch + Lomb Corporation (BLCO) Gets a Hold from Morgan StanleyBausch + Lomb Corp Equal-Weight with price target revised from 13.00 to 14.00.

Yi Chen

H.C. Wainwright

$16→$17

Buy

9.47%

Upside

Reiterated

10/31/25

Bausch + Lomb price target raised to $17 from $16 at H.C. WainwrightBausch + Lomb price target raised to $17 from $16 at H.C. Wainwright

Robbie Marcus

J.P. Morgan

$13→$16

Hold

3.03%

Upside

Reiterated

10/30/25

Bausch + Lomb price target raised to $16 from $13 at JPMorganBausch + Lomb price target raised to $16 from $13 at JPMorgan

Larry Biegelsen

Wells Fargo

$15→$16

Hold

3.03%

Upside

Reiterated

10/30/25

Wells Fargo Sticks to Their Hold Rating for Bausch + Lomb Corporation (BLCO)

Douglas Miehm

RBC Capital

$17

Buy

9.47%

Upside

Reiterated

10/30/25

Analysts Offer Insights on Healthcare Companies: Align Tech (NASDAQ: ALGN), Bausch + Lomb Corporation (NYSE: BLCO) and LivaNova (NASDAQ: LIVN)

Jack Scalprey

TR | OpenAI - 4o

$15→$16

Hold

3.03%

Upside

Reiterated

10/30/25

AI Generated ArticleAI Generated Article

Unknown Analyst

Evercore ISI

Not Ranked

Evercore ISI

$17→$18

Buy

15.90%

Upside

Reiterated

10/30/25

Evercore ISI Reaffirms Their Buy Rating on Bausch + Lomb Corporation (BLCO)

Travis Steed

Bank of America Securities

$13

Sell

-16.29%

Downside

Reiterated

10/29/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (NYSE: BLCO), United Therapeutics (NASDAQ: UTHR) and Unicycive Therapeutics (NASDAQ: UNCY)

Thomas Stephan

Stifel Nicolaus

$14

Hold

-9.85%

Downside

Reiterated

10/29/25

Cautious Outlook for Bausch + Lomb: Hold Rating Amid Mixed Performance and Challenging Guidance

Unknown Analyst

Evercore ISI

Not Ranked

Evercore ISI

$16.5→$17

Buy

9.47%

Upside

Reiterated

10/07/25

Bausch + Lomb Corporation (BLCO) Gets a Buy from Evercore ISI

Joanne Wuensch

Citi

$15→$16

Hold

3.03%

Upside

Reiterated

10/07/25

Bausch + Lomb price target raised to C$16 from C$15 at CitiBausch + Lomb price target raised to C$16 from C$15 at Citi

David Roman

Goldman Sachs

$16

Hold

3.03%

Upside

Initiated

10/01/25

Bausch + Lomb initiated with a Neutral at Goldman SachsBausch + Lomb initiated with a Neutral at Goldman Sachs

Unknown Analyst

Evercore ISI

Not Ranked

Evercore ISI

$16→$16.5

Buy

6.25%

Upside

Reiterated

07/31/25

Evercore ISI Sticks to Their Buy Rating for Bausch + Lomb Corporation (BLCO)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bausch + Lomb Corporation

1 Month

xxx

Success Rate

10/24 ratings generated profit

Average Return

-1.09%

reiterated a xxx

rating 9 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 41.67% of your transactions generating a profit, with an average return of -1.09% per trade.

3 Months

xxx

Success Rate

13/24 ratings generated profit

Average Return

+1.70%

reiterated a xxx

rating 9 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 54.17% of your transactions generating a profit, with an average return of +1.70% per trade.

1 Year

Douglas MiehmRBC Capital

Success Rate

12/24 ratings generated profit

Average Return

+1.63%

reiterated a buy rating 9 days ago

Copying Douglas Miehm's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +1.63% per trade.

2 Years

xxx

Success Rate

10/24 ratings generated profit

Average Return

+0.09%

reiterated a xxx

rating 9 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 41.67% of your transactions generating a profit, with an average return of +0.09% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BLCO Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BLCO has received 5 Buy Ratings, 20 Hold Ratings, and 2 Sell Ratings. BLCO average Analyst price target in the past 3 months is 15.82.

Each month's total comprises the sum of three months' worth of ratings.

BLCO Financial Forecast

BLCO Earnings Forecast

Next quarter’s earnings estimate for BLCO is $0.36 with a range of $0.30 to $0.42. The previous quarter’s EPS was $0.18. BLCO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year BLCO has Preformed in-line its overall industry.

BLCO Sales Forecast

Next quarter’s sales forecast for BLCO is $1.38B with a range of $1.36B to $1.41B. The previous quarter’s sales results were $1.28B. BLCO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year BLCO has Preformed in-line its overall industry.

BLCO Stock Forecast FAQ

What is BLCO’s average 12-month price target, according to analysts?

Based on analyst ratings, Bausch + Lomb Corporation’s 12-month average price target is 15.82.

What is BLCO’s upside potential, based on the analysts’ average price target?

Bausch + Lomb Corporation has 1.87% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is BLCO a Buy, Sell or Hold?

Bausch + Lomb Corporation has a consensus rating of Hold which is based on 3 buy ratings, 8 hold ratings and 1 sell ratings.

What is Bausch + Lomb Corporation’s price target?

The average price target for Bausch + Lomb Corporation is 15.82. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $18.00 ,the lowest forecast is $13.00. The average price target represents 1.87% Increase from the current price of $15.53.

What do analysts say about Bausch + Lomb Corporation?

Bausch + Lomb Corporation’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of BLCO?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Bausch + Lomb Corporation (BLCO) Stock Forecast & Price Target

BLCO Analyst Ratings

BLCO Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Bausch + Lomb Corporation

BLCO Analyst Recommendation Trends

BLCO Financial Forecast

BLCO Earnings Forecast

BLCO Sales Forecast

BLCO Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts